Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

EverSlim vs Transparent Meds

EverSlim
Graded #68

Higher grade

vs+11.600000000000001
Transparent Meds
Graded #282

Lower grade

The verdict

EverSlim takes it — 73.5/100 to 61.9/100.

EverSlim grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. EverSlim is a US telehealth programme selling doctor-prescribed compounded GLP-1 medication delivered to the door, with compounded semaglutide from $117 a month and compounded tirzepatide from $140 a month.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEverSlim +37
80
43
Dose & formulationTransparent Meds +13
64
77
Clinical oversightTransparent Meds +3
76
79
Labs & monitoringEverSlim +11
63
52
FulfillmentEverSlim +23
97
74
Contract termsEverSlim +14
55
41
EverSlim · left barTransparent Meds · right bar

The numbers

MetricEverSlimTransparent Meds
WeighScore73.5/10061.9/100
GradeCC
Scorecard rank#68#282
Semaglutide$117/mo (compounded)$229/mo (promotional rate, compounded)
Tirzepatide$140/mo (compounded)$349/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
EverSlim

Graded #68 · C

Strengths

  • Transparent flat pricing from 127 dollars a month for compounded semaglutide; medication, provider visit, and shipping included with no insurance.
  • Names its pharmacy partners (EPIQ Scripts, Foothills, Emerald) and DrTelx medical group; LegitScript-approved and NABP-accredited.
  • Available in all 50 states and DC, with asynchronous care in 44 states and live-visit access in the rest.
  • Offers both semaglutide and tirzepatide, plus care-team messaging between visits.

Where it loses points

  • No price tiers are published anywhere: /pricing is a 404, the footer pricing link is a same-page anchor, and the checkout is behind a login, so what a titrated dose costs is unknowable before signing up
  • Cancellation requires at least 72 hours' notice before the next billing date, or the subscription renews for another cycle
  • Asynchronous care covers 44 states; DC, Kansas, Louisiana, Mississippi, New Mexico, Rhode Island and West Virginia require a live video consult
  • Marketing says 'No membership' while the cancellation policy repeatedly calls it a membership and a subscription
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Transparent Meds

Graded #282 · C

Strengths

  • Transparent, upfront monthly pricing — intro $149/mo for compounded semaglutide and $249/mo for tirzepatide (regular $229 / $349)
  • Clean, modern telehealth experience with a quick eligibility quiz and clinician review before any prescription
  • HIPAA-compliant and displays a LegitScript-style verification seal

Where it loses points

  • Headline prices are intro first-month fees — the regular monthly cost is higher ($229 semaglutide, $349 tirzepatide)
  • Connector model that pairs you with licensed providers; it doesn't name its compounding pharmacy
  • Doesn't publish the states it serves, so confirm availability before signing up
  • Compounded semaglutide and tirzepatide injections only — no oral, brand-name, or insurance options

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard